List view / Grid view
Support your kinase inhibitor drug discovery programs with the most comprehensive kinase assay menu from DiscoverX’s KINOMEscan screening and profiling services, now with the fastest available turnaround time of 5 days for the ELECT services*...
The S3e Cell Sorter demonstrates its utility in performing high purity sorts of adherent cells that express intercellular florescent proteins...
This new guide reviewing the material and methods with HTRF® Toolbox reagents is for you...
Monitoring cellular drug penetration and drug-target interaction enables assessment of compound efficacy and confirmation of mode of action...
Integrating the S3e™ Cell Sorter into sample preparation upstream of the QX200™ Droplet Digital System provided details about cell subpopulations that would have been undetectable in heterogeneous populations...
A new Bio-Plex Pro chemokine panel was validated for quantifying 40 human chemokines in one sample offering a significant advantage to researchers...
Cisbio Bioassays has developed a GPCR platform based on the company’s HTRF® technology to measure second messenger accumulation...
Novel candidate drug targets for systemic scleroderma were identified using RNAi in phenotypic assays in scleroderma patient-derived fibroblasts...
This technical note gives you critical insights into on how to run, optimise and validate this ERK assay on your own cellular materials...
This short, easy-to-read Application Note goes over the background and basics of ERK signaling in multiple GPCR models...
In this whitepaper, discover the applications of Bio-Plex Pro cell signalling Akt and MAPK assay panels in signal transduction pathways...
In this application note, learn how to reduce time and sample consumption while achieving highly reproducible results from your assays with HTRF technology...
This whitepaper highlights how commercial tools can reduce assay development time and enable a biologic developer to get to market or submission before competitors...
In this whitepaper, ADDF partner with Charles River and an expert advisory panel of academic, industry and government scientists to make recommendations on best practices for animal studies testing investigational AD therapies...
Selective and non-selective positive allosteric modulators were evaluated for their effects on GABAA α1β1γ2L and α1β2γ2L subtypes...
